Fundraising FoxProteoWise, Inc.
New Haven, US · Founded 2018 · Delaware corporation · 3 known investors
Find your way into ProteoWise, Inc.
Sign up to find every way you can get introduced to ProteoWise, Inc.
- Your email: who you already know at ProteoWise, Inc., and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ProteoWise, Inc. team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
ProteoWise develops the Hyperblot benchtop instrument for high-throughput multiplexed proteomics, letting researchers load samples and antibody panels to obtain quantified western-style protein data. It targets life-science researchers working in areas such as neuroscience, cancer, and immunology.
Founders & leadership
ProteoWise, Inc. was founded in 2018 by Stephen M. Strittmatter and Misha Kostylev.
Board
Investors · 3
How we know: Connecticut Innovations's portfolio page · the company's own site · funding news · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$11.3M disclosed across 3 rounds · 2020–2024
▶$2.3MraisedDec 2024 · 6 investors · BiotechnologyRule 506(b)
- Daniel WagnerDirector
- Benjamin D. CombDirector
- Erik GuntherExecutive Officer, Director
- David SmollerDirector
- Offering amount
- $10M
- Amount sold
- $2.3M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MraisedApr 2021 · 5 investors · BiotechnologyRule 506(b)
- Erik GuntherExecutive Officer, Director, Promoter
- Benjamin CombDirector
- Daniel WagnerDirector
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6.3MraisedMar 2020 · 15 investors · BiotechnologyRule 506(b)
- Benjamin CombDirector
- Erik GuntherExecutive Officer, Director, Promoter
- Daniel WagnerDirector
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- Finders' fees
- $89.7K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $251.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does ProteoWise, Inc. do?
- ProteoWise develops the Hyperblot benchtop instrument for high-throughput multiplexed proteomics, letting researchers load samples and antibody panels to obtain quantified western-style protein data. It targets life-science researchers working in areas such as neuroscience, cancer, and immunology.
- Who founded ProteoWise, Inc.?
- ProteoWise, Inc. was founded by Stephen M. Strittmatter, Misha Kostylev in 2018.
- Who are ProteoWise, Inc.'s investors?
- ProteoWise, Inc.'s investors include Connecticut Innovations, Foothill Ventures, Taihill Venture.
- How much funding has ProteoWise, Inc. raised?
- ProteoWise, Inc. has disclosed $11.3M raised across 3 rounds.
- Where is ProteoWise, Inc. headquartered?
- ProteoWise, Inc. is headquartered in New Haven, US.